Overview
CRVS market data
Price History
No market bars yet for CRVS. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CRVS. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy?The Motley Fool · Jun 23, 2026, 8:01 PM
Corvus Pharma Participates In New $13.5M Financing For Angel PharmaceuticalsBenzinga · Jun 9, 2026, 11:40 AM
8-K filing — Corvus Pharmaceuticals, Inc. (CRVS)SEC EDGAR · May 14, 2026, 11:01 AM